Aggressive Intravenous Hydration With Lactated Ringer's Solution for Prevention of Post-ESWL Pancreatitis

NACompletedINTERVENTIONAL
Enrollment

1,066

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

March 18, 2025

Study Completion Date

March 23, 2025

Conditions
Pancreatitis, ChronicPancreatic Duct Stone
Interventions
DRUG

Lactated ringers solution

Intravenous 20 mL/kg Ringer's lactate solution within 60 min from the start of ESWL, directly followed by 3 mL/kg per h for 8 h.

DRUG

normal saline

Intravenous fluid infusion with normal saline (maximum of 1.5mL/kg per h or 3L per 24h).

Trial Locations (1)

200433

Changhai Hospital, Shanghai

All Listed Sponsors
collaborator

Ruijin Hospital

OTHER

collaborator

LanZhou University

OTHER

collaborator

First People's Hospital of Hangzhou

OTHER

collaborator

The Second Affiliated Hospital of Baotou Medical College

OTHER

collaborator

Shanghai Pudong New Area Gongli Hospital

OTHER

collaborator

Peking Union Medical College Hospital

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

The Third Xiangya Hospital of Central South University

OTHER

collaborator

Affiliated Hospital of Yunnan University

OTHER

lead

Changhai Hospital

OTHER

NCT05772234 - Aggressive Intravenous Hydration With Lactated Ringer's Solution for Prevention of Post-ESWL Pancreatitis | Biotech Hunter | Biotech Hunter